French biopharmaceutical company Axoltis Pharma has announced promising results from its phase 1b clinical trial evaluating NX210c - an innovative therapy for neurodegenerative diseases and traumas.
An Edinburgh med-tech company has received almost half a million pounds in UK Government funding to develop an assistive robotic glove for stroke patients.
Two leading standards bodies have launched a new group aimed at connecting global neuroscience and genomic data to speed up research
Professor Per Saris at the University of Helsinki said: "Our findings are significant, as the cause of Parkinson's disease has gone unknown despite attempts to identify it throughout the last two centuries"
The injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) has a long-lasting effect that appears to protect the brain from further damage, new research has found.
Rates of dementia are rising exponentially. By 2050, 153 million people are expected to be living with the condition worldwide. But a societal fear of the condition has produced a stigma that cannot easily be shaken off.
Dementia is among the public’s most feared conditions, second only to cancer. For many, a diagnosis signifies the end of their life. This fear, coupled with a lack of understanding of what it means to live with the condition, means patients are often pushed away and left feeling isolated.
Brain injuries can be severe. Even mild concussions can see [...]
More than 150 million women worldwide use oral contraceptives. Combined OCs (COCs), made up of synthetic hormones, are the most common type. Sex hormones are known to modulate the brain network involved in fear processes. Now a team of researchers in Canada has investigated the current and lasting effects of COC use, as well as the role of body-produced and synthetic sex hormones on fear-related brain regions, the neural circuitry via which fear is processed in the brain.
News, insight and campaigning for everyone working in neurorehabilitation: the right rehab, at the right time, for everyone who needs it.
Get the newsletterOur membersOther Aspect Health Media Titles
Copyright © 2026 Aspect Health Media Ltd
